US › Healthcare

P3 Health Partners Inc (PIII)

US · Healthcare · Medical Care Facilities

$10.38+3.59%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$386.4M
Revenue YoY
+3.5%
Net profit
$1.2M
Profit YoY
+106.0%
EPS
$0.32
EPS estimate
$-3.50
Net margin
0.3%

EPS came in at 0.32 against a street estimate of -3.50 — a beat of 109.1%.

Key statistics

Market cap
$2.13B
Forward P/E
0.0
P/B
0.62
Book value
$-43.99
EPS (TTM)
$-39.36
52-week high
$16.89
52-week low
$1.52
50-day MA
$11.35
200-day MA
$6.01
Beta
1.62

Analyst view

Analysts rate P3 Health Partners Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $14.00.

Shareholding

Insiders
56.91%
Institutions
7.79%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC2.12%
Vanguard Group Inc1.45%
Geode Capital Management, LLC0.78%
CI Private Wealth LLC0.60%
Nine Masts Capital Limited0.54%
HRT FINANCIAL LLC0.45%
Diversified Trust Co0.40%
Susquehanna International Group, LLP0.40%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for P3 Health Partners Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.